Update to living WHO guideline on drugs for covid-19

BMJ. 2021 Mar 31:372:n860. doi: 10.1136/bmj.n860.
No abstract available

MeSH terms

  • Antiparasitic Agents / adverse effects
  • COVID-19 / diagnosis
  • COVID-19 / epidemiology
  • COVID-19 / virology
  • COVID-19 Drug Treatment*
  • Guidelines as Topic
  • Humans
  • Ivermectin / adverse effects*
  • Pharmaceutical Preparations
  • SARS-CoV-2 / drug effects*
  • SARS-CoV-2 / genetics
  • World Health Organization

Substances

  • Antiparasitic Agents
  • Pharmaceutical Preparations
  • Ivermectin